Merck, 1460339-25MG, Nepafenac Related Compound B

Name: Nepafenac Related Compound B
Brand: Merck
SKU: 1460339-25MG

Size:25 mg, 7-Benzoylindolin-2-one, United States Pharmacopeia (USP) Reference Standard

Catalog Number: 1460339-25MG

Pricing

Send an RFQ.

View RFQ List

Category

Polymer Standards

Pack Size25 mg

TagsAnalytical Chemistry Reference Materials Pharma Standards

CollectionsMerck Certified Reference Materials: CRMs for Calibration, QC & Instrument Validation Merck Cell Culture Supplements & Reagents: Complete Solutions for Research & Bioproduction Merck Roche Life Science Products for PCR, RT‑PCR & Nucleic Acid Purification

Description

General description
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Application
Nepafenac Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.

Specifications

General

MDL number	MFCD11974010
UNSPSC Code	41116107
NACRES	NA.24
InChI	1S/C15H11NO2/c17-13-9-11-7-4-8-12(14(11)16-13)15(18)10-5-2-1-3-6-10/h1-8H,9H2,(H,16,17)
InChI key	APGQYYFHBPQPTL-UHFFFAOYSA-N
API family	nepafenac
manufacturer/tradename	USP
application(s)	pharmaceutical (small molecules)
format	neat
storage temp.	2-8°C

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.